Wedge Capital Management L L P Enanta Pharmaceuticals Inc Transaction History

Wedge Capital Management L L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 08, 2020	SELL	$43.36 - $53.53 $211,640 - $261,279	-4,881 Closed	0 $0
Q2 2020 Jul 10, 2020	SELL	$46.37 - $57.58 $67,236 - $83,491	-1,450 Reduced 22.9%	4,881 $245,000
Q1 2020 Apr 13, 2020	BUY	$40.22 - $62.0 $32,537 - $50,158	809 Added 14.65%	6,331 $326,000
Q4 2019 Jan 15, 2020	BUY	$57.95 - $66.61 $32,625 - $37,501	563 Added 11.35%	5,522 $341,000
Q3 2019 Nov 01, 2019	BUY	$60.08 - $88.17 $297,936 - $437,235	4,959 New	4,959 $298,000

108

19.7M

9.7K

12.4K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $131M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Wedge Capital Management L L P, based on Form 13F filings with the SEC.

Stay updated on Wedge Capital Management L L P with notifications on news.